How Is First-Line Treatment Changing? / advanced urothelial carcinoma, bladder cancer, cancer, cancer care, Cancer research, ...

Bladder and Urothelial Cancer Trials to Watch at ESMO 2026 / bladder cancer, cancer, cancer care, Cancer research, cancer ...

For more information about ERNA-101 and the Company’s development plans, visit About ERNA-101. ERNA-101 is Ernexa’s lead ...

For appropriately selected patients with muscle-invasive bladder cancer, preserving the bladder can be a curative treatment option rather than removing it, according to a new clinical guideline from ...

Please provide your email address to receive an email when new articles are posted on . 28% of Medicare beneficiaries received their cancer diagnosis after an ED visit. Individuals diagnosed via ...

Enrolling in a clinical trial offers a unique opportunity to participate in cancer research. “Today’s standard treatments were once clinical trials,” says Fernando Maciel Barbosa, MD, a medical ...

July 31 (Reuters) - We also report a new and improved way of monitoring Parkinson's disease medication levels. A new immunotherapy helped many ‌patients with an aggressive form of bladder cancer avoid ...

Neoadjuvant cisplatin-based chemotherapy is a standard therapy for muscle-invasive bladder cancer. The efficacy and safety of neoadjuvant and adjuvant (perioperative) enfortumab vedotin–pembrolizumab ...

Most people with bladder cancer begin treatment by having surgery to remove their cancer. If bladder cancer has spread beyond your bladder, you might have chemotherapy first. This can help treat ...

If you do not have the PowerPoint desktop app, you can always use the PowerPoint Web version. The online version of PowerPoint is available for free, and you can use it on a computer as well as a ...

An informed multiplex PCR circulating tumor DNA–based molecular residual disease test could inform adjuvant treatment following cystectomy. The NCCN has updated its Clinical Practice Guidelines in ...

A total of 42% of 48 evaluable patients enrolled in the Nexus-01 trial saw their tumors shrink after treatment with LY4052031. (Darren Incorvaia) Eli Lilly arrived at the American Society of Clinical ...